Dr. Sulaiman Al Habib Medical Journal

In Press, Corrected Proof, Available Online: 3 December 2020

Dexamethasone as a Treatment of COVID-19

Authors
Abdullah Alkattan1, 2, *, ORCID, Mahmoud Kandeel1, 3, *
1Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa, Saudi Arabia
2Chronic Disease Prevention Center, Ministry of Health, Riyadh, Saudi Arabia
3Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh, Egypt
*Corresponding authors. Email: abdullahalkattan@gmail.com; mkandeel@kfu.edu.sa
Corresponding Author
Abdullah Alkattan
Received 5 October 2020, Accepted 14 November 2020, Available Online 3 December 2020.
DOI
https://doi.org/10.2991/dsahmj.k.201125.001How to use a DOI?
Keywords
COVID-19, SARS-CoV-2, cytokine storm, dexamethasone
Abstract

Severe acute respiratory syndrome coronavirus 2 is the causative agent of coronavirus disease 2019 (COVID-19), one of the fatal pandemic diseases in the 20th and 21st centuries. Given the absence of definitive treatment, computational and clinical repurposing of drugs was practiced to combat this disease. Cytokine storm was cited as the primary cause of death during COVID-19. In this context, corticosteroid drugs such as dexamethasone attracted considerable interest in treating this viral infection. In general, based on current studies, dexamethasone appears to be a safe and effective treatment option for moderate or severe respiratory diseases caused by COVID-19.

Copyright
© 2020 Dr. Sulaiman Al Habib Medical Group. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

Journal
Dr. Sulaiman Al Habib Medical Journal
Publication Date
2020/12
ISSN (Online)
2590-3349
ISSN (Print)
2666-819X
DOI
https://doi.org/10.2991/dsahmj.k.201125.001How to use a DOI?
Copyright
© 2020 Dr. Sulaiman Al Habib Medical Group. Publishing services by Atlantis Press International B.V.
Open Access
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Cite this article

TY  - JOUR
AU  - Abdullah Alkattan
AU  - Mahmoud Kandeel
PY  - 2020
DA  - 2020/12
TI  - Dexamethasone as a Treatment of COVID-19
JO  - Dr. Sulaiman Al Habib Medical Journal
SN  - 2590-3349
UR  - https://doi.org/10.2991/dsahmj.k.201125.001
DO  - https://doi.org/10.2991/dsahmj.k.201125.001
ID  - Alkattan2020
ER  -